Basf Corporation v. Ingevity South Carolina, LLC ( 2023 )


Menu:
  • Case: 22-1129   Document: 58     Page: 1   Filed: 06/22/2023
    NOTE: This disposition is nonprecedential.
    United States Court of Appeals
    for the Federal Circuit
    ______________________
    BASF CORPORATION,
    Appellant
    v.
    INGEVITY SOUTH CAROLINA, LLC,
    Appellee
    ______________________
    2022-1129
    ______________________
    Appeal from the United States Patent and Trademark
    Office, Patent Trial and Appeal Board in No. PGR2020-
    00037.
    ______________________
    Decided: June 22, 2023
    ______________________
    PAUL ALESSIO MEZZINA, King & Spalding LLP, Wash-
    ington, DC, argued for appellant. Also represented by
    JOSHUA NATHANIEL MITCHELL; BRIAN EUTERMOSER,
    MIKAELA STONE, Denver, CO.
    BRIAN BUROKER, Gibson, Dunn & Crutcher LLP, Wash-
    ington, DC, argued for appellee. Also represented by
    VLADIMIR J. SEMENDYAI; KATHERINE QUINN DOMINGUEZ,
    New York, NY; NATHANIEL RYAN SCHARN, BRIAN YANG, Ir-
    vine, CA.
    Case: 22-1129    Document: 58     Page: 2    Filed: 06/22/2023
    2        BASF CORPORATION   v. INGEVITY SOUTH CAROLINA, LLC
    ______________________
    Before LOURIE, DYK, and STOLL, Circuit Judges.
    STOLL, Circuit Judge.
    BASF Corporation appeals the Patent Trial and Appeal
    Board’s final written decision determining that BASF
    failed to show that certain claims of 
    U.S. Patent No. 10,323,553
     were unpatentable as indefinite or obvious.
    We affirm in part, vacate in part, and remand. In particu-
    lar, we hold that, based on its statement that it need not
    consider BASF’s evidence, the Board failed to properly con-
    sider the record evidence and adequately explain its ra-
    tionale for indefiniteness. We therefore vacate the Board’s
    indefiniteness determination and remand for further pro-
    ceedings. We otherwise find no reversible error in the
    Board’s obviousness determination and affirm the Board’s
    decision in that regard.
    BACKGROUND
    Ingevity South Carolina, LLC owns the ’553 patent,
    which relates to systems for reducing fuel vapor emissions
    in low purge conditions, e.g., in hybrid vehicles. ’553 pa-
    tent col. 1 ll. 22–25, col. 2 ll. 55–65.
    Gasoline-powered motor vehicles are equipped with a
    vented fuel tank to allow for fuel vapors to expand and con-
    tract. As a result, fuel vapors escape to the atmosphere
    through the fuel tank’s vent and pollute the air. These fuel
    vapor emissions are known as diurnal breathing losses
    (DBLs). To reduce fuel vapor emissions, engineers devel-
    oped adsorption canister systems. First, honeycomb-
    shaped volumes made of adsorbent material, such as acti-
    vated carbon, collect fuel vapors while allowing other com-
    ponents to pass through. But adsorbent volumes can only
    adsorb so much vapor; so, once the adsorbent volumes
    reach their limit, non-adsorbed fuel vapors escape into the
    atmosphere. To address this issue, the vehicle’s engine—
    Case: 22-1129       Document: 58       Page: 3   Filed: 06/22/2023
    BASF CORPORATION     v. INGEVITY SOUTH CAROLINA, LLC          3
    while on—draws air back through the canister, and the ad-
    sorbed fuel vapors are drawn back into the engine (desorp-
    tion) and burned (purge). This canister system, however,
    was not as effective for hybrid vehicles because the engines
    in hybrid vehicles do not run as frequently as traditional
    gasoline-powered vehicles and thus spend less time in this
    second, desorption phase. Hence, hybrid vehicles operate
    in “low purge” conditions.
    The ’553 patent purports to reduce fuel vapor emis-
    sions in hybrid vehicles using a canister system with an
    initial adsorbent volume and at least one subsequent ad-
    sorbent volume with lower adsorptive properties (i.e.,
    lesser adsorptive capacity) than the initial adsorption vol-
    ume. ’553 patent Abstract. For example, as depicted below
    in Figure 4 of the patent, fuel-side adsorbent volume 201
    would have a higher adsorption capacity than at least one
    of the subsequent adsorbent volumes 202, 203, 204, or
    301:
    
    Id.
     at Fig. 4, col. 4 l. 61–col. 5 l. 3.
    Claim 1 is illustrative and describes the characteristics
    of the adsorbent volumes:
    Case: 22-1129      Document: 58    Page: 4    Filed: 06/22/2023
    4         BASF CORPORATION   v. INGEVITY SOUTH CAROLINA, LLC
    1. An evaporative emission control canister system,
    including one or more canisters and comprising:
    a fuel-side adsorbent volume having an ef-
    fective incremental adsorption capacity at
    25° C. of greater than 35 grams n-butane/L
    between vapor concentration of 5 vol % and
    50 vol % n-butane; and
    at least one subsequent adsorbent volume
    having an effective incremental adsorption
    capacity at 25° C. of less than 35 grams n-
    butane/L between vapor concentration of 5
    vol % and 50 vol % n-butane, an effective
    butane working capacity (BWC) of less
    than 3 g/dL, and a g-total BWC of ≤6 grams,
    wherein the fuel-side adsorbent volume
    having an effective incremental adsorption
    capacity at 25° C. of greater than 35 grams
    n-butane/L between vapor concentration of
    5 vol % and 50 vol % n-butane, and the at
    least one subsequent adsorbent volume are
    located within a single canister, or in sepa-
    rate canisters that are connected to permit
    sequential contact by fuel vapor, and
    wherein the canister system has a two-day
    diurnal breathing loss (DBL) of no more
    than 20 mg at no more than 100 BV of
    purge applied after a 40 g/hr butane load-
    ing step.
    
    Id.
     at col. 23 ll. 18–40.
    BASF, a competitor in the design and manufacture of
    carbon honeycombs, petitioned for post-grant review of
    claims 1–10, 14–28, 32–38, 51, 52, 55–57, 59, 64–72, and
    76–82 of the ’553 patent. BASF asserted that the chal-
    lenged claims are indefinite and would have been obvious
    Case: 22-1129    Document: 58     Page: 5    Filed: 06/22/2023
    BASF CORPORATION   v. INGEVITY SOUTH CAROLINA, LLC        5
    over Hiltzik1 in view of Clontz WIPO 2 and Clontz SAE. 3
    Hiltzik is Ingevity’s own patent, shares two common inven-
    tors with the ’553 patent, and discloses similar subject
    matter as the limitations of claim 1, but not the low-purge
    performance limitation: “wherein the canister system has
    a two-day diurnal breathing loss (DBL) of no more than
    20 mg at no more than 100 BV of purge applied after a
    40 g/hr butane loading step.” The Board held that BASF
    had not shown the challenged claims were unpatentable
    under either ground. BASF Corp. v. Ingevity S.C., LLC,
    2021 Pat. App. LEXIS 5450, at *47–48 (P.T.A.B. Sept. 9,
    2021) (Decision).
    BASF appeals. We have jurisdiction under 
    28 U.S.C. § 1295
    (a)(4)(A).
    DISCUSSION
    BASF challenges the Board’s indefiniteness and obvi-
    ousness determinations.     Ingevity challenges BASF’s
    standing for this appeal. We address the threshold issue
    4
    of standing before addressing the Board’s indefiniteness
    and obviousness determinations.
    I
    We begin with standing. Ingevity argues that BASF
    lacks standing because BASF failed to provide evidence of
    1    U.S. Patent No. RE38,844.
    2    WO 2009/061533 A1.
    3   Clontz, R., et al., Effects of Low-Purge Vehicle Ap-
    plications and Ethanol-Containing Fuels on Evaporative
    Emissions Canister Performance, SOC’Y AUTO. ENG’RS
    JAPAN (2007).
    4   Ingevity filed a motion to terminate BASF’s appeal,
    alleging that BASF lacked Article III standing. ECF No. 9.
    We denied the motion and directed the parties to address
    standing in their merits briefing. ECF No. 20.
    Case: 22-1129     Document: 58     Page: 6    Filed: 06/22/2023
    6        BASF CORPORATION    v. INGEVITY SOUTH CAROLINA, LLC
    a likely infringing act in the United States or concrete busi-
    ness plans for a BASF product that could lead to such an
    act. Appellee’s Br. 58. Specifically, Ingevity contends that
    BASF does not explain what testing, manufacturing, or
    selling of its products has occurred in the United States;
    BASF has not explicitly named interested customers; and
    BASF’s business plans are speculative in light of the
    lengthy validation process required for products on vehicle
    platforms in the United States. 
    Id.
     at 58–62.
    BASF contends that it has standing because Ingevity
    previously sued it for infringement of Hiltzik—directed to
    an invention similar to the ’553 patent—based on BASF’s
    use and testing of EvapTrap XC, its previously produced
    activated carbon product. Appellant’s Br 62–65; see Com-
    plaint, Ingevity Corp. v. BASF Corp., No. 1:18CV01391,
    
    2018 WL 11360396
     (D. Del. Sept. 6, 2018). Mr. Joseph
    Moonjely, BASF’s in-house counsel, explained that BASF’s
    product was developed to be used in U.S. vehicles and to
    meet U.S. emissions standards, and BASF can currently
    manufacture and provide its product to customers. Appel-
    lant’s Br. 62–65 (citing Moonjely Decl. ¶¶ 9, 29–30); Reply
    Br. 34–35. Mr. Moonjely also stated that interested cus-
    tomers have inquired about the product’s pricing and in-
    ventory for use on vehicle platforms in the United States.
    Moonjely Decl. ¶ 29.
    BASF, as the party invoking federal jurisdiction, bears
    the burden of establishing standing. Spokeo, Inc. v. Rob-
    ins, 
    578 U.S. 330
    , 338 (2016), as revised (May 24, 2016). To
    establish Article III standing, BASF must show: (1) it “suf-
    fered an injury in fact, (2) that is fairly traceable to the
    challenged conduct of the defendant, and (3) that is likely
    to be redressed by a favorable judicial decision.” 
    Id.
     To
    demonstrate the requisite injury in an appeal from a final
    written decision in a post grant review, “we have concluded
    that it is generally sufficient for the appellant to show that
    it has engaged in, is engaging in, or will likely engage in
    ‘activity that would give rise to a possible infringement
    Case: 22-1129    Document: 58     Page: 7    Filed: 06/22/2023
    BASF CORPORATION   v. INGEVITY SOUTH CAROLINA, LLC        7
    suit.’” Grit Energy Sols., LLC v. Oren Techs., LLC,
    
    957 F.3d 1309
    , 1319 (Fed. Cir. 2020) (quoting Consumer
    Watchdog v. Wis. Alumni Rsch. Found., 
    753 F.3d 1258
    ,
    1262 (Fed. Cir. 2014)). BASF “need not face ‘a specific
    threat of infringement litigation by the patentee’ to estab-
    lish jurisdiction,” but rather need only “generally show a
    controversy ‘of sufficient immediacy and reality’ to warrant
    the requested judicial relief.” E.I. DuPont de Nemours
    & Co. v. Synvina C.V., 
    904 F.3d 996
    , 1004 (Fed. Cir. 2018)
    (quoting ABB Inc. v. Cooper Indus., LLC, 
    635 F.3d 1345
    ,
    1348 (Fed. Cir. 2011)).
    We are satisfied that BASF has met its burden of es-
    tablishing standing. “[F]or purposes of assessing stand-
    ing,” we accept Mr. Moonjely’s declaration “as true . . .
    material representations of fact.” Amerigen Pharms. Ltd.
    v. UCB Pharma GmBH, 
    913 F.3d 1076
    , 1083 (Fed. Cir.
    2019). We have previously found a substantial risk of fu-
    ture infringement where the appellant “operates a plant
    [that is] capable of infringing the . . . patent” at issue.
    DuPont, 
    904 F.3d at
    1004–05. We have also held that prior
    litigation involving, for example, the patent-in-suit or re-
    lated patents “presents an even stronger basis for stand-
    ing.”    Google LLC v. Conversant Wireless Licensing
    S.A.R.L., 
    753 F. App’x 890
    , 894 (Fed. Cir. 2018) (non-prec-
    edential) (finding appellants’ risk of infringement concrete
    and substantial where appellant was previously accused of
    patent infringement by the appellee); see also Adidas AG
    v. Nike, Inc., 
    963 F.3d 1355
    , 1357 (Fed. Cir. 2020) (finding
    the appellant had standing where the appellee asserted the
    patent-at-issue against a third-party product similar to
    that of the appellant’s). Here, BASF has demonstrated
    that it plans to sell its product in the United States and
    was previously sued by Ingevity. Because BASF “has con-
    crete plans for future activity that create[] a substantial
    risk of future infringement or likely cause the patentee to
    assert a claim of infringement,” JTEKT Corp. v. GKN Auto.
    Ltd., 
    898 F.3d 1217
    , 1221 (Fed. Cir. 2018), we conclude that
    Case: 22-1129    Document: 58      Page: 8    Filed: 06/22/2023
    8        BASF CORPORATION   v. INGEVITY SOUTH CAROLINA, LLC
    BASF has satisfied the requirements for Article III stand-
    ing.
    II
    We thus proceed to the merits of BASF’s appeal. We
    review the Board’s ultimate conclusions of indefiniteness
    and obviousness de novo and its underlying fact determi-
    nations for substantial evidence. Guangdong Alison Hi-
    Tech Co. v. Int’l Trade Comm’n, 
    936 F.3d 1353
    , 1359
    (Fed. Cir. 2019); TQ Delta, LLC v. CISCO Sys., Inc., 
    942 F.3d 1352
    , 1357 (Fed. Cir. 2019). The substantial evidence
    standard asks whether, after examining the record evi-
    dence, “a reasonable fact finder could arrive at the agency’s
    decision.” TQ Delta, 942 F.3d at 1358.
    BASF challenges the Board’s findings that (1) two
    methods of measuring adsorption capacity—the gravimet-
    ric and volumetric measurement methods—are compara-
    ble; and (2) a skilled artisan would not have been
    motivated to dilute Hiltzik’s honeycomb to achieve lower
    emissions in view of Clontz SAE. We address each issue in
    turn.
    A
    BASF challenges the Board’s rejection of its indefinite-
    ness ground as being arbitrary and capricious and not sup-
    ported by substantial evidence. Appellant’s Br. 30–43.
    The challenged claims recite “an effective incremental ad-
    sorption capacity.” For example, Claim 1 requires “a fuel-
    side adsorbent volume having an effective incremental ad-
    sorption capacity [(IAC)] . . . of greater than 35 grams n-
    butane/L” and “at least one subsequent adsorbent volume
    having an effective incremental adsorption capacity . . . of
    less than 35 grams n-butane/L.” ’553 patent col. 9 ll. 6–25,
    col. 23 ll. 20–26 (emphases added). The ’553 patent dis-
    closes two different methods of measuring effective IAC: a
    gravimetric method and a volumetric method. Id. at col. 13
    l. 60–col. 14 l. 54.
    Case: 22-1129    Document: 58      Page: 9    Filed: 06/22/2023
    BASF CORPORATION   v. INGEVITY SOUTH CAROLINA, LLC         9
    BASF argued before the Board that the challenged
    claims are indefinite because the patent specification fails
    to teach with reasonable certainty how the effective IAC
    should be measured, and the specification articulates two
    measurement methods that give varying results. Appel-
    lant’s Br. 30–31 (“[W]hen ‘different approaches to measure-
    ment are involved,’ the patent ‘must disclose a single
    known approach or establish that, where multiple known
    approaches exist, a [skilled artisan] would know which ap-
    proach to select.’” (quoting Dow Chem. Co. v. Nova Chems.
    Corp. (Can.), 
    803 F.3d 620
    , 630 (Fed. Cir. 2015)). In sup-
    port, BASF offered a memorandum from its expert
    Dr. Guo, as well as third-party testing, to show alleged sig-
    nificant differences between results determined using the
    gravimetric and volumetric methods. See Decision, 2021
    Pat. App. LEXIS 5450, at *17; J.A. 2055; J.A. 3092.
    In response, Ingevity offered contrary evidence, such as
    peer-reviewed articles and expert testimony, to show that
    the two measurement methods “were known to measure
    equivalent adsorption capacities and were viewed as com-
    patible with each other.” Decision, 2021 Pat. App. LEXIS
    5450, at *17. This evidence showed, Ingevity argued, that
    the large differences found in BASF’s testing resulted from
    “instrument inaccuracies and experimental error.” 
    Id.
    The Board ultimately found that BASF had not estab-
    lished indefiniteness of the claims by a preponderance of
    the evidence. Id. at *18. On appeal, BASF argues that the
    Board credited Ingevity’s evidence and failed to consider its
    contrary evidence of indefiniteness, including its third-
    party testing evidence. Appellant’s Br. 37–40. The Board’s
    opinion states in relevant part:
    We find that the evidence submitted by Patent
    Owner as to the gravimetric and volumetric meas-
    urement techniques demonstrates that they were
    well established in the art as comparable methods
    for   measuring      adsorption    capacity,  and
    Case: 22-1129     Document: 58     Page: 10    Filed: 06/22/2023
    10        BASF CORPORATION   v. INGEVITY SOUTH CAROLINA, LLC
    accordingly, not a basis for determining claim in-
    definiteness.
    Because this determination is dispositive as to Pe-
    titioner’s indefiniteness challenge, we need not ad-
    dress Petitioner’s allegations as to the measurement
    differences . . . .
    Decision, 2021 Pat. App. LEXIS 5450, at *19 (emphasis
    added; citations omitted).
    The Board’s statement suggests that, because it found
    Ingevity’s evidence on indefiniteness convincing, the Board
    did not consider BASF’s evidence on the issue.
    Substantial evidence review “asks whether a reasona-
    ble fact finder could have arrived at the agency’s decision,
    and involves examination of the record as a whole, taking
    into account evidence that both justifies and detracts from
    an agency’s decision.” TQ Delta, 942 F.3d at 1358 (quota-
    tions omitted). Although our review under the Administra-
    tive Procedure Act (APA) is deferential, id., the Board must
    “explain[] its decisions with sufficient precision, including
    the underlying factfindings and [its] rationale,” Packard
    Press, Inc. v. Hewlett-Packard Co., 
    227 F.3d 1352
    , 1357
    (Fed. Cir. 2000). Indeed, “the Board may not short-cut its
    consideration of the factual record before it.” Princeton
    Vanguard, LLC v. Frito-Lay N. Am., Inc., 
    786 F.3d 960
    , 970
    (Fed. Cir. 2015); see 
    id.
     (“Though the Board is not required
    to discuss every piece of evidence, it cannot . . . disregard
    [the appellant’s] evidence without explanation.”).
    At oral argument, Ingevity asserted that the Board did
    weigh BASF’s evidence against Ingevity’s. For example,
    Ingevity suggested the Board noted that Dr. Zielinski, who
    oversaw BASF’s third-party testing, also wrote one of the
    peer-reviewed publications submitted by Ingevity. See
    Oral       Arg.      at 16:12–17:13,      https://oralargu-
    ments.cafc.uscourts.gov/default.aspx?fl=22-1129_0503202
    3.mp3. In Ingevity’s view, the Board made a credibility
    Case: 22-1129    Document: 58     Page: 11   Filed: 06/22/2023
    BASF CORPORATION   v. INGEVITY SOUTH CAROLINA, LLC       11
    finding and determined that Dr. Zielinski’s peer-reviewed
    article was more reliable than the third-party testing, in
    light of the other evidence in the record. 
    Id.
     In other
    words, Ingevity argued that the Board considered the evi-
    dence submitted by BASF and Ingevity, and ultimately de-
    termined that Ingevity’s evidence established that the
    volumetric and gravimetric techniques are comparable
    methods in the art. 
    Id.
     at 16:12–17:43; see 
    id.
     at 18:12–
    18:26 (“All you have to do is find a path to their outcome,
    which is clear—[the Board] found the peer-reviewed arti-
    cles . . . and unbiased materials to be more compelling.”).
    But the Board did not explain whether it found Ingevity’s
    evidence more credible; nor did it explain whether it found
    BASF’s testing unreliable and therefore did not give that
    evidence any weight. See 
    id.
     at 17:43–18:16. While we may
    well have affirmed the Board had it articulated any of these
    purported reasons for its conclusion, we cannot meaning-
    fully review the Board’s opinion to determine whether its
    underlying factual finding is supported by substantial evi-
    dence because we cannot discern the basis for the Board’s
    finding—other than its very clear statement that it need
    not consider BASF’s evidence. Such a statement, without
    further elaboration, runs afoul of the APA’s requirement to
    consider all the evidence and thus the Board’s analysis is
    improper.
    We therefore vacate the Board’s decision regarding
    BASF’s indefiniteness challenge and remand for the Board
    to consider all the proffered evidence of record and make
    the relevant factual findings and legal conclusion regard-
    ing indefiniteness.
    B
    We now turn to BASF’s challenge to the Board’s finding
    on motivation to combine the asserted prior art. Appel-
    lant’s Br. 43–61. Claim 1 is illustrative and requires “at
    least one subsequent adsorbent volume having . . . an ef-
    fective butane working capacity (BWC) of less than 3 g/dL,
    Case: 22-1129    Document: 58      Page: 12    Filed: 06/22/2023
    12       BASF CORPORATION    v. INGEVITY SOUTH CAROLINA, LLC
    and a g-total BWC of ≤6 grams” and “the canister system
    ha[ving] a two-day diurnal breathing loss (DBL) of no more
    than 20 mg at no more than 100 BV of purge applied after
    a 40 g/hr butane loading step.” See ’553 patent col. 23
    ll. 24–40. In its petition, BASF asserted that Hiltzik,
    Clontz WIPO, and Clontz SAE taught this limitation—spe-
    cifically, that a skilled artisan would have been motivated
    to dilute the honeycomb in Hiltzik’s Example 2 in view of
    the teachings of the two Clontz references that such a dilu-
    tion would be preferable in a low purge environment.
    J.A. 214–16; see also Decision, 2021 Pat. App. LEXIS 5450,
    at *28–29.
    The Board found that BASF had not established by a
    preponderance of the evidence that a skilled artisan would
    have been motivated to dilute Hiltzik’s honeycomb adsor-
    bent “to meet emissions standards at low-purge conditions
    in view of Clontz SAE and Clontz WIPO.” 5 
    Id.
     at *32–36.
    The Board was persuaded by Ingevity’s argument that
    Clontz SAE expressly teaches that “higher working capac-
    ity honeycombs ‘facilitate achievement of target emissions
    5   Although both parties assert that the Board found
    that Clontz SAE teaches away from the claimed invention,
    we understand the Board’s opinion as holding that a person
    of ordinary skill in the art would not have been motivated
    to modify Hiltzik in view of the Clontz references because
    Clontz SAE teaches an alternative solution to the same
    low-purge problem present in the ’553 patent. See, e.g., Ap-
    pellant’s Br. 27–28; Appellee’s Br. 2. Indeed, the Board’s
    decision does not use the legal term “teaching away,” nor
    does it analyze the stringent criteria required for establish-
    ing teaching away. See Rembrandt Wireless Techs., LP
    v. Samsung Elecs. Co., 
    853 F.3d 1370
    , 1379 (Fed. Cir. 2017)
    (“Whether a reference teaches away is doctrinally distinct
    from whether there is no motivation to combine prior art
    references.”).
    Case: 22-1129   Document: 58      Page: 13   Filed: 06/22/2023
    BASF CORPORATION   v. INGEVITY SOUTH CAROLINA, LLC      13
    levels under the reduced purge conditions.’” 
    Id.
     at *32–33
    (quoting J.A. 2272).
    On appeal, BASF challenges the Board’s finding that a
    skilled artisan would not have been motivated to combine
    Hiltzik with the Clontz references. Specifically, BASF ar-
    gues that contrary to the Board’s finding, Clontz WIPO
    suggests diluting Hiltzik’s honeycomb with its teaching us-
    ing adsorbents with flatter isotherms, including voids in
    the adsorbents, and reducing the honeycomb’s resistance.
    Appellant’s Br. 43–60; see also 
    id.
     at 44–51.
    We hold that the Board’s finding—that a skilled arti-
    san would not have been motivated to make the proposed
    combination of Hiltzik and the Clontz references—is sup-
    ported by substantial evidence. Clontz SAE discloses using
    “higher capacity honeycombs” than the honeycombs in
    Hiltzik to achieve “target emissions levels under the re-
    duced purge conditions.” J.A. 2272. Clontz SAE teaches
    that canister emissions were generally better in large vol-
    umes, as shown by a larger honeycomb exhibiting lower
    emissions levels than the smaller honeycomb at purge vol-
    umes less than 200 bed volumes. J.A. 2268–69. A reason-
    able factfinder could therefore find that Clontz SAE would
    have motivated a skilled artisan to use a higher BWC in
    subsequent adsorbent volumes.
    While BASF introduced evidence arguably demon-
    strating a motivation to combine—e.g., BASF’s expert opin-
    ing that the skilled artisan would have been motivated
    because both Hiltzik and Clontz WIPO teach diluting the
    honeycomb (either by flattening its isotherm or reducing
    its resistance) to achieve better emissions and reduce its
    IAC and BWC—the Board considered this evidence. In-
    stead, the Board found that Clontz SAE never mentions di-
    lution as a means to address the problem with low-purge
    conditions. See Decision, 2021 Pat. App. LEXIS 5450,
    at *33–34. Given the varied record evidence—with some
    supporting BASF’s view and some supporting Ingevity’s
    Case: 22-1129     Document: 58      Page: 14    Filed: 06/22/2023
    14          BASF CORPORATION   v. INGEVITY SOUTH CAROLINA, LLC
    view—the Board was entitled to reasonably reach its fac-
    tual finding. “This court does not reweigh evidence on ap-
    peal, but rather determines whether substantial evidence
    supports the Board’s fact findings.” In re NTP, Inc., 
    654 F.3d 1279
    , 1292 (Fed. Cir. 2011). Therefore, we conclude
    that substantial evidence supports a finding of no motiva-
    tion to combine.
    CONCLUSION
    We have considered BASF’s remaining arguments and
    find them unpersuasive. For the foregoing reasons, BASF
    has standing to appeal the Board’s final written decision.
    Because the Board did not explain why it disregarded
    BASF’s proffered evidence regarding the measurement
    techniques, we vacate the Board’s indefiniteness determi-
    nation and remand for further proceedings consistent with
    this opinion. Because substantial evidence supports the
    Board’s finding no motivation to combine, we affirm the
    Board’s obviousness determination.
    AFFIRMED-IN-PART, VACATED-IN-PART, AND
    REMANDED
    COSTS
    No costs.